Earlier this year, WWARN conducted a survey of researchers who had contributed data to the WWARN platform. The aim was to understand researcher preferences about how your data are accessed and used thereafter. In response to this feedback, WWARN is developing new models of how data can be shared and...

We urge all involved in malaria studies and / or malaria clinical trials to use this opportunity to comment on the new CDISC Malaria Therapeutic Area User Guide (TAUG-Malaria).

The WorldWide Antimalarial Resistance (WWARN) is joining forces with other emerging and infectious disease communities through the newly-formed Infectious Diseases Data Observatory (IDDO).

Resistance to the artemisinin component of artemisinin combination therapies (ACTs),has emerged in parts of Southeast Asia. Locations with low malaria transmission and intense drug selection pressure are seen as potential hot spots for new outbreaks of drug resistant malaria. The identification of ...

P. falciparum malaria infection can be successfully treated using a combination of artemisinin derivatives and a partner drug, known together as artemisinin combination therapies (ACTs). However, signs of resistance to both the artemisinin derivative and partner drugs have emerged in many parts of t...

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions. A new project will assess a variety of portable and handheld devices used to assess the quality of medicines.

A new article published in The BMJ outlines experiences and investigates the advantages and costs of different data sharing models.

The WWARN Pharmacology Proficiency Testing (PT) programme has now been granted official Proficiency Testing Provider accreditation according to ISO 17043:2010.

The Infectious Diseases Data Observatory's new film shows the potential impact of data sharing on infectious diseases research.

The Infectious Diseases Data Observatory was officially launched on Wednesday 7 September as part of the Oxford Tropical Network meeting, an opportunity for those working in tropical medicine and global health to learn about each other’s work and forge new collaborations.

An international collaboration led by researchers from the Institut Pasteur in Cambodia, and the Institut Pasteur and CNRS in France, has recently identified in the malaria parasite Plasmodium falciparum genetic changes that are found in parasites resistant to artemisinin treatment in Cambodia. Thes...

New genome sequencing technologies provide insight into emerging artemisinin-resistance and a novel way to track this public health threat

Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to artemisinin, the recommended front line treatment for malaria in north-western Thailand, adjacent to Myanmar (Burma), is reported in The Lancet today. This increases concern that resistance cou...

An international network of malaria scientists is to be established to map the emergence of resistance to antimalarial drugs and guide global efforts to control and eradicate the disease, thanks to a $20m (£12.5m) grant from the Bill & Melinda Gates Foundation.

The UK All Party Parliamentary Group on Malaria & NTDs (APPMG) recently released a report entitled ‘Racing Against Time: Protecting the Gains Achieved in Malaria Control Against Drug Resistance’

Draft standards are expected to be ready for release for public review by August 2016.

A database of individual participant-level information could benefit schistosomiasis clinical research and treatment policies, according to a study published today in PLOS Neglected Tropical Diseases.

Malaria infection during pregnancy can seriously affect the lives of the pregnant mother, foetus and newborn baby.